Fmoc-Thr[GalNAc(Ac)3-α-D]-OH structure
|
Common Name | Fmoc-Thr[GalNAc(Ac)3-α-D]-OH | ||
---|---|---|---|---|
CAS Number | 116783-35-8 | Molecular Weight | 670.660 | |
Density | 1.4±0.1 g/cm3 | Boiling Point | 857.1±65.0 °C at 760 mmHg | |
Molecular Formula | C33H38N2O13 | Melting Point | 178-183 °C | |
MSDS | N/A | Flash Point | 472.1±34.3 °C |
Use of Fmoc-Thr[GalNAc(Ac)3-α-D]-OHFmoc-Thr[GalNAc(Ac)3-α-D]-OH i a building block in the development of cancer vaccine. |
Name | N-Fmoc-O-[3,4,6-tri-O-acetyl-2-(acetylamino)-2-deoxy-α-D-galactopyranosyl]-L-threonine |
---|---|
Synonym | More Synonyms |
Description | Fmoc-Thr[GalNAc(Ac)3-α-D]-OH i a building block in the development of cancer vaccine. |
---|---|
Related Catalog | |
In Vitro | The O-glycosidic linkage and the O-acetyl protection in this building block is stable to both piperidine and TFA, making it completely compatible with standard protocols in Fmoc solid phase peptide synthesis. The Tn antigen is a tumor-associated carbohydrate antigen that is not normally expressed in peripheral tissues or blood cells. Expression of this antigen, which is found in a majority of human carcinomas of all types, arises from a blockage in the normal O-glycosylation pathway in which glycans are extended from the common precursor GalNAcα1-O-Ser/Thr (Tn +antigen). This precursor is generated in the Golgi apparatus on newly synthesized glycoproteins by a family of polypeptide α- N-acetylgalactosaminyltransferases (ppGalNAcTs) and then extended to the common core 1 O-glycan Galβ1-3GalNAcα1-OSer/Thr (T antigen) by a single enzyme termed the T-synthase (core 1 β3-galactosyltransferase or C1GalT). Formation of the active form of the T-synthase requires a unique molecular chaperone termed Cosmc, encoded by Cosmc on the X-chromosome[1]. |
References |
Density | 1.4±0.1 g/cm3 |
---|---|
Boiling Point | 857.1±65.0 °C at 760 mmHg |
Melting Point | 178-183 °C |
Molecular Formula | C33H38N2O13 |
Molecular Weight | 670.660 |
Flash Point | 472.1±34.3 °C |
Exact Mass | 670.237366 |
PSA | 202.09000 |
LogP | 4.58 |
Vapour Pressure | 0.0±0.3 mmHg at 25°C |
Index of Refraction | 1.592 |
Storage condition | -15°C |
RIDADR | NONH for all modes of transport |
---|
Precursor 9 | |
---|---|
DownStream 0 |
FMOC-THR(GALNAC(AC)3-α-D)-OH |
α-D-Galactopyranoside, (1R,2S)-2-carboxy-2-[[(9H-fluoren-9-ylmethoxy)carbonyl]amino]-1-methylethyl 2-(acetylamino)-2-deoxy-, 3,4,6-triacetate |
(2R,3R)-3-{[(2S,3R,4R,5R,6R)-3-Acetamido-4,5-diacetoxy-6-(acetoxymethyl)tetrahydro-2H-pyran-2-yl]oxy}-2-{[(9H-fluoren-9-ylmethoxy)carbonyl]amino}butanoic acid (non-preferred name) |
(2S,3R)-3-{[(2S,3R,4R,5R,6R)-3-Acetamido-4,5-diacetoxy-6-(acetoxymethyl)tetrahydro-2H-pyran-2-yl]oxy}-2-{[(9H-fluoren-9-ylmethoxy)carbonyl]amino}butanoic acid |
α-D-Galactopyranoside, (1R,2R)-2-carboxy-2-[[(9H-fluoren-9-ylmethoxy)carbonyl]amino]-1-methylethyl 2-(acetylamino)-2-deoxy-, 3,4,6-triacetate |
Fmoc-Thr[GalNAc(Ac)3-α-D]-OH |